If you have atopic dermatitis (eczema), this guide will help you prepare for what to except during your initial doctor's appointment, including questions to ask, tests that might be ordered, and how ...

Learn more about whether Moderna, Inc. or Roivant Sciences Ltd. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Nektar Therapeutics (NKTR) stock climbed as Jefferies upgraded the company to buy ahead of a Phase 2b trial readout for ...

Dupilumab in atopic dermatitis treatment had the most favorable cardiometabolic safety profile when compared with methotrexate and cyclosporine.

Conduit Pharmaceuticals (CDT) announces the filing of two groundbreaking patents for tapinarof, VTAMA, including a dual active cocrystal, ...

Conduit Pharmaceuticals files next generation cocrystal patent for VTAMA®(tapinarof) which the Company believes could be a superior asset with both inflammatory and autoimmune prospectives just as the ...

Jefferies upgraded Nektar (NKTR) to Buy from Hold with a price target of $2, up from $1. The company’s rezpegaldesleukin will report topline ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Arcutis Biotherapeutics, Inc.’s ARQT share price has dipped by 11.05%, which has investors questioning if this is right time ...

The sparsity of mid-to-late stage prospects in atopic dermatitis (AD, or eczema) – which has proved an especially challenging indication – plus some newsmaking fizzles in the space have caused ...

Raj Chovatiya, MD, PhD, MSCI, highlights promising research in atopic dermatitis focused on identifying patient subgroups for targeted treatments and achieving long-term remission.

An expert discusses the existing gaps in atopic dermatitis (AD) management, promising areas of research to address unmet needs, and key takeaways from the discussion for the managed care audience ...